How many insider trades does FilingIQ track for AURA?

FilingIQ tracks 128 Form 4 insider transactions for AURA (Aura Biosciences, Inc.), covering filings from Oct 28, 2021 onwards. 19 of those were filed in the last 90 days.

Are AURA insiders net buyers or net sellers?

Across the full Form 4 history for AURA, 29 transactions (23%) were open-market purchases and 39 (30%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does AURA insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is AURA in?

Aura Biosciences, Inc. (AURA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $333.39M.

AURA insider trading

Healthcare

Aura Biosciences, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

128

Last 90 days

Buys / sells

23% / 30%

Market cap

$333.39M

About Aura Biosciences, Inc.

Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer, as an alternative to bacillus calmetteguérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.

Company website: www.aurabiosciences.com

AURA insider activity at a glance

FilingIQ has scored 128 insider transactions for AURA since Oct 28, 2021. The most recent filing in our index is dated May 7, 2026.

Across the full history, 29 open-market purchases and 39 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on AURA insider trades is 53.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live AURA trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

13F funds holding AURA

Decheng Capital Management III (Cayman), LLC

$18.24M · 6.1% of AUM

Frequently asked

How many insider trades does FilingIQ track for AURA?: FilingIQ tracks 128 Form 4 insider transactions for AURA (Aura Biosciences, Inc.), covering filings from Oct 28, 2021 onwards. 19 of those were filed in the last 90 days.
Are AURA insiders net buyers or net sellers?: Across the full Form 4 history for AURA, 29 transactions (23%) were open-market purchases and 39 (30%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does AURA insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is AURA in?: Aura Biosciences, Inc. (AURA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $333.39M.

Methodology & sources

Every AURA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.